Researchers identify best drug therapy for rare, aggressive pancreatic cancer

Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care.

Radiation therapy associated with a lower risk of recurrence in people with pancreatic cancer

Radiation therapy improves survival times in patients who are candidates for pancreatic cancer surgery.

FISH helps identify biliary tract malignancies

Michael J. Levy, M.D., a consultant in Gastroenterology and Hepatology at Mayo Clinic's campus in Rochester, Minnesota, discusses clinical utility, optimum specimen collection methods.

New model to assess breast cancer risk more accurate than current option

A new breast cancer risk-prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the ...

Mayo researchers developing a new way to screen for endometrial cancer

Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons.

Mayo Clinic researcher on factors to improve breast cancer risk prediction

Mayo Clinic researcher Fergus J. Couch, Ph.D., discusses a study show that combined 77 common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer.

Methylated DNA markers and whole-body cancer screening

John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors.

Researchers locate master cutoff switch for cancer-causing HER2 protein

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.

Ibrutinib with chemotherapy offers longer life to people with B-Cell cancers

Researchers found that a combination of ibrutinib and chemotherapy reduced the risk of death or cancer progression by 80 percent in people with previously treated chronic lymphocytic leukemia.

Proton therapy has advantages over IMRT for advanced nasal cavity and paranasal sinus cancer

Robert L. Foote, M.D., comments on findings of a new study by radiation oncologists at Mayo Clinic, comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base.

Minimally invasive inguinal lymph node dissection (MILND)

Jakub James, M.D., demonstrates the operative technique of minimally invasive inguinal lymph node dissection in patients with melanoma. This video is intended for a surgical audience and is not intended to replace hands-on training.

Treatment for people with cholangiocarcinoma at Mayo Clinic

Rory L. Smoot, M.D., describes treatment options and the specialized team of experts at Mayo Clinic who provide care for patients with cholangiocarcinoma.